PCSK9 as a therapeutic target of dyslipidemia
作者： Nabil G Seidah
DOI: 10.1517/14728220802600715
关键词:
摘要: … However, in all these crystal structures a number of unresolved segments were … structure diffractions. The most obvious information that can be deduced from these PCSK9 structures …
informapharmascience.com参考文章(93)
Thilina Dewpura, Angela Raymond, Josée Hamelin, Nabil G. Seidah, Majambu Mbikay, Michel Chrétien, Janice Mayne, PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans. FEBS Journal. ,vol. 275, pp. 3480- 3493 ,(2008) , 10.1111/J.1742-4658.2008.06495.X
Jamie Cameron, Øystein L. Holla, Knut Erik Berge, Mari Ann Kulseth, Trine Ranheim, Trond P. Leren, Jon K. Laerdahl, Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion FEBS Journal. ,vol. 275, pp. 4121- 4133 ,(2008) , 10.1111/J.1742-4658.2008.06553.X
Michael S Brown, Joseph L Goldstein, Lowering LDL--Not Only How Low, But How Long? Science. ,vol. 311, pp. 1721- 1723 ,(2006) , 10.1126/SCIENCE.1125884
R. E. Hammer, Y.-A. Moon, J. D. Horton, S. Rashid, D. E. Curtis, R. Garuti, N. N. Anderson, Y. Bashmakov, Y. K. Ho, Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 5374- 5379 ,(2005) , 10.1073/PNAS.0501652102
Sanae Kourimate, Cedric Le May, Cédric Langhi, Anne Laure Jarnoux, Khadija Ouguerram, Yassine Zaïr, Patrick Nguyen, Michel Krempf, Bertrand Cariou, Philippe Costet, Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/Kexin Type 9 Journal of Biological Chemistry. ,vol. 283, pp. 9666- 9673 ,(2008) , 10.1074/JBC.M705831200
Rossi P. Naoumova, Isabella Tosi, Dilip Patel, Clare Neuwirth, Stuart D. Horswell, A. David Marais, Charles van Heyningen, Anne K. Soutar, Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 25, pp. 2654- 2660 ,(2005) , 10.1161/01.ATV.0000190668.94752.AB
Weijun Jin, Ilia V. Fuki, Nabil G. Seidah, Suzanne Benjannet, Jane M. Glick, Daniel J. Rader, Proprotein Covertases Are Responsible for Proteolysis and Inactivation of Endothelial Lipase Journal of Biological Chemistry. ,vol. 280, pp. 36551- 36559 ,(2005) , 10.1074/JBC.M502264200
Vivienne M. Homer, A. David Marais, Francesca Charlton, Andrew D. Laurie, Nicola Hurndell, Russel Scott, Fabien Mangili, David R. Sullivan, Philip J. Barter, Kerry-Anne Rye, Peter M. George, Gilles Lambert, Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis. ,vol. 196, pp. 659- 666 ,(2008) , 10.1016/J.ATHEROSCLEROSIS.2007.07.022
Gilles Lambert, Unravelling the functional significance of PCSK9. Current Opinion in Lipidology. ,vol. 18, pp. 304- 309 ,(2007) , 10.1097/MOL.0B013E3281338531
Alan R. Tall, Protease variants, LDL, and coronary heart disease. The New England Journal of Medicine. ,vol. 354, pp. 1310- 1312 ,(2006) , 10.1056/NEJME068026